Skip to content
‹ Back to IndustriesSciences

Intermittent Fasting Can Benefit People with Type 2 Diabetes. Can “Mindful Eating” Provide Similar Health Rewards with Less Structure?

To improve holistic bodily health, intermittent fasting may replace snack time for many, possibly even for people with type 2 diabetes. A recent review out of the journal Clinical Diabetes and Endocrinology shows evidence that intermittent fasting can reduce not only body weight but insulin resistance as well in people with type 2 diabetes, along with…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · FastingIntermittent FastingMindful EatingRamadan
Share

Key takeaways

01

To improve holistic bodily health, intermittent fasting may replace snack time for many, possibly even for people with type 2 diabetes.

02

A recent review out of the journal Clinical Diabetes and Endocrinology shows evidence that intermittent fasting can reduce not only body weight but insulin resistance as well in people with type 2 diabetes, along with…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

To improve holistic bodily health, intermittent fasting may replace snack time for many, possibly even for people with type 2 diabetes. A recent review out of the journal Clinical Diabetes and Endocrinology shows evidence that intermittent fasting can reduce not only body weight but insulin resistance as well in people with type 2 diabetes, along with helping regulate levels of the hormone leptin, which signals the brain when a person is full. As worldwide diabetes projections rise to 643 million by 2030 and 783 million by 2045, and 1.4 million Americans are diagnosed with diabetes yearly, the science and healthcare communities are weighing a wide variety of options for how to treat this epidemic. What role does intermittent fasting play in those options, and are there similar strategies that would act as a better alternative?

The most common method to produce intermediate fasting benefits is time-restricted feeding. It allows for eating during specific hours a day, with 16–20-hour daily fasts. This isn’t the only fasting strategy, though, and the concept of intermittent fasting in fact has a rich history. Another approach is daily fasting from dawn to sunset as practiced during Ramadan. A recent study in Metabolism Open focuses on this type of intermittent fasting which aligns meal and sleep times with the body’s natural rhythm. It may have potential benefits such as optimizing the body’s immune functions.

Common across these versions of fasting is a structured, repeated and consistent pace to eating (or not eating). A less structured approach, though, such as mindful eating, may be just as beneficial. Sheila H. Forman, licensed clinical psychologist, mindful eating coach and founder of TAME Your Appetite, gives a healthy serving of advice on the benefits of intermittent fasting, and why a mindful eating strategy could prove just as useful for scientists and physicians to tackle related health crises. 

Sheila’s Thoughts

“Intermittent fasting is the intentional withholding of food and drink for hours at a time without regard to the body’s hunger and fullness. Proponents of intermittent fasting say that intentionally fasting may have health benefits. For example, giving the body this period of rest gives it a chance to use its own energy and stores things like sugar and fat before more food is consumed.

In addition, intermittent fasting is also said to provide health benefits because it purposefully reduces the amount of food, namely calories that a person consumes any given day. We all know that a reduction in calories has been shown to help with diseases. A reduction in calories has been shown to reduce the risk of things like obesity, heart disease, cancer, dementia, and diabetes.

In our 24/7 world, it is easy to eat excessively and never truly give our bodies a chance to rest or properly digest the food that it has previously eaten. But you don’t have to use intermittent fasting to accomplish all these health benefits.

Mindful eating can do that for you while also honoring your body’s own hunger and fullness signals, also known as using inner wisdom. Mindful eating very simply is eating with the awareness of your body’s needs and preferences. When a person pays attention to their body and allows their body to guide them what, when, and how much to eat, they naturally have periods of time in their day when they’re not eating and their body is actively and efficiently processing and utilizing the food previously eaten, and those episodes will be in sync with their body’s actual needs, and not created by the specific timeframes that are imposed by intermittent fasting.

Furthermore, with practice, the mindful eater learns how to eat the right amount of calories for their body so that any excess weight that they may be carrying is lost. So if a person is looking for a way to enhance their health by making sure that their body is given the time it needs to do its thing, they have to look no further than their own inner wisdom and a mindful approach to eating.”

Article written by Sonya Young.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512